Form 4: CME Group Director Carey Acquires Shares
Statement of Changes in Beneficial Ownership
CME Group Director Charles P. Carey acquired shares through the company's annual equity compensation program and in lieu of cash retainer.
Summary
- Charles P. Carey, a Director at CME Group Inc., acquired shares of Class A Common Stock on June 25, 2026.
- The acquisition included a grant of 645 fully vested shares as part of the annual equity compensation for non-employee directors.
- Additionally, 422 shares were acquired in lieu of a portion of his annual cash retainer for serving on the Board of Directors.
- These shares were valued at $225 each at the time of the transaction.
- Following these transactions, Carey beneficially owns 6,424 shares indirectly through a trust, 6,846 shares indirectly through a trust, 185 shares indirectly by a firm, and 0.375 shares indirectly by a partnership.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine director compensation and not a significant strategic or financial event.
Positives
- Director compensation is being utilized through stock grants, aligning director interests with shareholders.
- The company has a structured annual equity compensation program for its non-employee directors.
- Director Carey is actively participating in the company's compensation structure, receiving both granted shares and shares in lieu of cash.
Future Outlook
This filing does not contain forward-looking statements or guidance.
Industry Context
StockSavvy.ai notes that the issuance of stock to directors is a common practice in the financial services industry, including exchanges like CME Group, to align executive and director interests with those of shareholders and to attract and retain talent.
Stakeholder Impact
- Shareholders: The acquisition of shares by a director through compensation programs can be viewed positively as it aligns director interests with shareholder value. The specific amounts are part of a standard compensation structure.
- Employees: This filing does not directly impact employees, but it reflects the company's compensation practices for its board members.
- Creditors: No direct impact on creditors is indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 05/06/2026 | Date of execution of Power of Attorney by Charles P. Carey. |
| 06/25/2026 | Transaction date for the acquisition of Class A Common Stock by Charles P. Carey. |
| 06/29/2026 | Date of signature for the Form 4 filing. |
Keywords
CME Group, Form 4, Director, Stock Acquisition, Equity Compensation, Beneficial Ownership, SEC Filing, Insider Trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.